Get started
Author

K. Olivier

Observed name: Kenneth R. Olivier
Institution: Mayo Clinic
Observed institution: Mayo Clinic
OpenAlex ID: A5018843356
MA03.05 Circulating Tumor DNA Tumor Fraction as a Precision Biomarker for Radiotherapy in Oligometastatic NSCLC
2025 · K. Parikh, N.P. Semenkovich, et al. · Journal of Thoracic Oncology · 1
FDG-PET Parameters as Predictors of Pathologic Response and Nodal Clearance in Patients with Stage III Non–small Cell Lung Cancer Receiving Neoadjuvant Chemoradiation and Surgery
2017 · A.L.H. Arnett, A. Packard, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
PDF
Abstract 1183: Early ctDNA quantification by ctFE outperforms Max VAF for survival stratification across locally advanced and oligometastatic NSCLC treated with radiotherapy.
2026 · Ayesha Hashmi, Jessica Linford, et al. · Cancer Research
Mid-Treatment ctDNA to Predict Outcomes in Stage IIB-IIIC NSCLC Treated with MRI-Adapted Chemoradiation
2025 · A. Hashmi, P.S. Chauhan, et al. · International Journal of Radiation Oncology*Biology*Physics
Proton Radiotherapy for Primary Lung Cancer in Patients with Interstitial Lung Disease
2024 · R. Roden, W.S. Harmsen, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
An Externally Validated RPA-Based Pre-Treatment Decision-Making Tool Identifying Ideal Candidates for Spine SBRT
2022 · R.O. Kowalchuk, T.C. Mullikin, et al. · International Journal of Radiation Oncology*Biology*Physics
Works count: 6
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type